1. Home
  2. GKOS vs VTMX Comparison

GKOS vs VTMX Comparison

Compare GKOS & VTMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Glaukos Corporation

GKOS

Glaukos Corporation

HOLD

Current Price

$118.87

Market Cap

6.3B

Sector

Health Care

ML Signal

HOLD

Logo Corporacion Inmobiliaria Vesta S.A.B de C.V. each representing ten (10)

VTMX

Corporacion Inmobiliaria Vesta S.A.B de C.V. each representing ten (10)

N/A

Current Price

$32.33

Market Cap

2.4B

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
GKOS
VTMX
Founded
1998
1998
Country
United States
Mexico
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.3B
2.4B
IPO Year
2015
2023

Fundamental Metrics

Financial Performance
Metric
GKOS
VTMX
Price
$118.87
$32.33
Analyst Decision
Strong Buy
Hold
Analyst Count
14
3
Target Price
$130.93
$30.50
AVG Volume (30 Days)
783.1K
62.4K
Earning Date
02-17-2026
02-19-2026
Dividend Yield
N/A
2.16%
EPS Growth
N/A
N/A
EPS
N/A
0.07
Revenue
$469,820,000.00
$271,805,969.00
Revenue This Year
$31.33
$13.43
Revenue Next Year
$24.01
$9.87
P/E Ratio
N/A
$45.74
Revenue Growth
30.38
11.74
52 Week Low
$73.16
$21.30
52 Week High
$161.78
$32.51

Technical Indicators

Market Signals
Indicator
GKOS
VTMX
Relative Strength Index (RSI) 53.50 63.32
Support Level $93.96 $31.20
Resistance Level $130.23 $32.45
Average True Range (ATR) 5.67 0.58
MACD 0.30 0.03
Stochastic Oscillator 65.67 85.41

Price Performance

Historical Comparison
GKOS
VTMX

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. It has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

About VTMX Corporacion Inmobiliaria Vesta S.A.B de C.V. each representing ten (10)

Corporacion Inmobiliaria Vesta SAB de CV is an internally managed real estate company that owns, manages, develops, and leases industrial properties in Mexico. The Company's primary business is the acquisition, development, and management of industrial and distribution center real estate. The company designs and constructs park-to-suit projects across various industries; undertakes build-to-suit projects; and provides site selection, design and engineering, and sale and leaseback services. The primary source of revenue is the rental income received from customers under operating leases. It serves aerospace, automotive, food and beverage, logistics, medical devices, plastics, and other industries.

Share on Social Networks: